<DOC>
	<DOCNO>NCT00591396</DOCNO>
	<brief_summary>A Phase I Trial ZIO-101 ( Darinaparsin ) Solid Tumors</brief_summary>
	<brief_title>A Phase I Trial ZIO-101 Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria 1 . Subjects histological confirmation solid malignancy refractory conventional standard therapy condition 2 . Eligible subject MUST least one measurable lesion define RECIST guideline . If measurable disease restrict solitary lesion , neoplastic nature confirm cytology/histology . Measurable lesion MUST previously irradiate field injected biological agent 3 . Pediatric subject eligible discretion primary investigator . 4 . ECOG performance status score ≤ 2 5 . Women childbearing potential ( i.e. , woman premenopausal surgically sterile ) must use acceptable contraceptive method ( abstinence , intrauterine device [ IUD ] , oral contraceptive double barrier device ) , must negative blood urine pregnancy test within 1 week begin treatment . Sexually active men must also use acceptable contraceptive method 6 . Subjects must provide write informed consent prior treatment 7 . At least 4 week prior completion prior therapy day 1 study drug 8 . Baseline toxicity assessment ≤ grade 1 except treatment induce alopecia ( NCI Common Toxicity Criteria version 3.0 ) 9 . Evidence adequate multiorgan functional status reflect follow clinical laboratory value : Serum creatinine ≤ 2 time upper normal limit OR calculate creatinine clearance ≥ 50 cc/min Total bilirubin ≤ 2 time upper normal limit Alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) ≤ 3 time upper limit normal 10 . Granulocytes peripheral blood great equal 1 x 10 ( 9 ) per liter , hemoglobin great equal 8.5 g/dL , platelet great equal 50,000 /microL Exclusion Criteria 1 . Uncontrolled systemic infection ( documented microbiological study ) 2 . Active heart disease define acute myocardial infarction within previous 6 month start therapy , stable unstable angina , clinically significant arrhythmia require medical management , OR New York Heart Association Classification Functional Activities . Class 3 : Subject marked limitation activity due symptom , even lessthanordinary activity comfortable rest OR Class 4 : Severe limitation . Subject experience symptoms even rest 3 . Concomitant therapy solid cancer 4 . Pregnant subject breastfeed 5 . History invasive second primary malignancy diagnose within previous 3 year except Stage I Endometrial/Cervical Carcinoma Prostate Carcinoma treat surgically , nonmelanoma skin cancer 6 . Documented personal family history prolong QT syndrome 7 . 12 lead electrocardiogram correct QT interval &gt; 460 millisecond 8 . History confusion dementia 9 . History seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>